Statistics
Publications
1
Citations
51
H-Index
1
Active since
2024
Affiliations
GlaxoSmithKline (United States)(Current)
Angham Al Saedi is an author at GlaxoSmithKline (United States) specializing in drug discovery, drug target validation, and covalent inhibitors.
Publications per year
2024–2024
1
1
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
Gabriele Picco, Yanhua Rao, Angham Al Saedi et al. · Cancer Discovery · 2024 · 51 citations · Full text
1–1 of 1